Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer

  • Zuo Yunxia1,
  • Cao Jun1,
  • Zhu Guanshan2,
  • Lu Yachao2,
  • Zhou Xueke1 and
  • Li Jin1Email author
Contributed equally
BMC Medical Genetics201011:34

DOI: 10.1186/1471-2350-11-34

Received: 11 August 2009

Accepted: 26 February 2010

Published: 26 February 2010

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
11 Aug 2009 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
24 Oct 2009 Reviewed Reviewer Report - Fahd Al-mulla
18 Nov 2009 Reviewed Reviewer Report - Alberto Bardelli
Resubmission - Version 4
Submitted Manuscript version 4
7 Jan 2010 Author responded Author comments - Cao Jun
Resubmission - Version 5
7 Jan 2010 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
Resubmission - Version 8
Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
Resubmission - Version 10
Submitted Manuscript version 10
18 Feb 2010 Author responded Author comments - Cao Jun
Resubmission - Version 11
18 Feb 2010 Submitted Manuscript version 11
Publishing
26 Feb 2010 Editorially accepted
26 Feb 2010 Article published 10.1186/1471-2350-11-34

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Medical Oncology, Fudan University Cancer Hospital, Shanghai Medical School
(2)
Innovation Center China, AstraZeneca Global R&D

Advertisement